Evidence map›Paper›PMID 38768238›Full record

ArticlePLoS pathogens2024

Pseudotyped virus infection of multiplexed ACE2 libraries reveals SARS-CoV-2 variant shifts in receptor usage.

Nidhi Shukla, Sarah M Roelle, John C Snell, Olivia DelSignore, Anna M Bruchez, Kenneth A Matreyek

Abstract read
In one paragraph

Article in PLoS pathogens, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Review
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

6 authors.

Nidhi ShuklaDepartment of Pathology, Case Western Reserve University School of Medicine, Cleveland, Ohio, United States of America.ORCID 0000-0001-5912-7039
Sarah M RoelleDepartment of Pathology, Case Western Reserve University School of Medicine, Cleveland, Ohio, United States of America.ORCID 0000-0002-2987-4137
John C SnellDepartment of Pathology, Case Western Reserve University School of Medicine, Cleveland, Ohio, United States of America.ORCID 0000-0003-2683-6108
Olivia DelSignoreDepartment of Pathology, Case Western Reserve University School of Medicine, Cleveland, Ohio, United States of America.
Anna M BruchezDepartment of Pathology, Case Western Reserve University School of Medicine, Cleveland, Ohio, United States of America.ORCID 0000-0003-1695-5349
Kenneth A MatreyekDepartment of Pathology, Case Western Reserve University School of Medicine, Cleveland, Ohio, United States of America.ORCID 0000-0001-9149-551X

Funding

TUMOR METABOLISM PROGRAMP30CA043703 · NCI · CASE WESTERN RESERVE UNIVERSITY · PI Amar Desai · 1987 to 2026
$142.3M
Recombinant DNA technologies for multiplex genetic assays in human cellsR35GM142886 · NIGMS · CASE WESTERN RESERVE UNIVERSITY · PI MATREYEK, KENNETH A · 2021 to 2025
$2.0M
Identification of Host Directed Drug Targets for SARS-CoV-2 Using Transposon MutagenesisR21AI161275 · NIAID · CASE WESTERN RESERVE UNIVERSITY · PI BRUCHEZ, ANNA · 2021 to 2021
$443k
Large-scale compatibility assessments between ACE2 proteins and diverse sarbecovirus spikesR21AI178151 · NIAID · CASE WESTERN RESERVE UNIVERSITY · PI MATREYEK, KENNETH A · 2023 to 2024
$443k
Functional genomic characterization of diverse bat innate immune mechanismsR21AI169561 · NIAID · CASE WESTERN RESERVE UNIVERSITY · PI BRUCHEZ, ANNA · 2023 to 2024
$443k
Multiplex discovery of synthetic host-protein combinations that inhibit HIVR21AI156907 · NIAID · CASE WESTERN RESERVE UNIVERSITY · PI MATREYEK, KENNETH A · 2021 to 2022
$443k
Intermediate-Featured Flow CytometerS10OD021559 · OD · CASE WESTERN RESERVE UNIVERSITY · PI JACOBBERGER, JAMES W · 2016 to 2016
$230k
NCI NIH HHS P30 CA043703NIAID NIH HHS R21 AI156907NIAID NIH HHS R21 AI161275NIAID NIH HHS R21 AI169561NIAID NIH HHS R21 AI178151NIGMS NIH HHS R35 GM142886NIH HHS S10 OD021559
6 · The paper itself

Abstract

Pairwise compatibility between virus and host proteins can dictate the outcome of infection. During transmission, both inter- and intraspecies variabilities in receptor protein sequences can impact cell susceptibility. Many viruses possess mutable viral entry proteins and the patterns of host compatibility can shift as the viral protein sequence changes. This combinatorial sequence space between virus and host is poorly understood, as traditional experimental approaches lack the throughput to simultaneously test all possible combinations of protein sequences. Here, we created a pseudotyped virus infection assay where a multiplexed target-cell library of host receptor variants can be assayed simultaneously using a DNA barcode sequencing readout. We applied this assay to test a panel of 30 ACE2 orthologs or human sequence mutants for infectability by the original SARS-CoV-2 spike protein or the Alpha, Beta, Gamma, Delta, and Omicron BA1 variant spikes. We compared these results to an analysis of the structural shifts that occurred for each variant spike's interface with human ACE2. Mutated residues were directly involved in the largest shifts, although there were also widespread indirect effects altering interface structure. The N501Y substitution in spike conferred a large structural shift for interaction with ACE2, which was partially recreated by indirect distal substitutions in Delta, which does not harbor N501Y. The structural shifts from N501Y greatly influenced the set of animal orthologs the variant spike was capable of interacting with. Out of the thirteen non-human orthologs, ten exhibited unique patterns of variant-specific compatibility, demonstrating that spike sequence changes during human transmission can toggle ACE2 compatibility and potential susceptibility of other animal species, and cumulatively increase overall compatibilities as new variants emerge. These experiments provide a blueprint for similar large-scale assessments of protein compatibility during entry by diverse viruses. This dataset demonstrates the complex compatibility relationships that occur between variable interacting host and virus proteins.

Indexed as

Angiotensin-Converting Enzyme 2COVID-19SARS-CoV-2Spike Glycoprotein, CoronavirusHEK293 CellsHumansMutationReceptors, VirusViral PseudotypingVirus InternalizationACE2 protein, humanAngiotensin-Converting Enzyme 2Receptors, VirusSpike Glycoprotein, Coronavirusspike protein, SARS-CoV-2

Identifiers

PMID38768238
PMCPMC11142672

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.